Company Filing History:
2 out of 7 
1 out of 5 Years Active: 2007-2012
Title: Pierre Beauparlant: Innovator in Cancer Treatment
Introduction
Pierre Beauparlant is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 3 patents, Beauparlant's work focuses on enhancing therapeutic methods for patients with specific health conditions.
Latest Patents
One of Beauparlant's latest patents involves compositions and methods for effecting NAD+ levels using a nicotinamide phosphoribosyl transferase inhibitor. This invention relates to methods for decreasing cellular DNA repair in a target patient, decreasing cellular NAD biosynthesis, and increasing the efficiency of radiation therapy. Additionally, it addresses the modulation of nicotinamide phosphoribosyl transferase activity and sensitizing patients to DNA damaging therapies. Another significant patent focuses on methods for treating patients diagnosed with chronic lymphocytic leukemia (CLL), aiming to improve their response to DNA damaging therapies.
Career Highlights
Throughout his career, Beauparlant has worked with prominent companies such as Gemin X Pharmaceuticals Canada Inc. and Gemin X Biotechnologies Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for cancer treatment.
Collaborations
Beauparlant has collaborated with notable coworkers, including Anne Roulston and Giorgio Attardo. These partnerships have likely enhanced his research and development efforts in the field of biotechnology.
Conclusion
Pierre Beauparlant's contributions to cancer treatment through his innovative patents demonstrate his commitment to improving patient outcomes. His work continues to influence the field of medical research and therapy.